Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico, Notification of Proposed Production Activity, Bristol-Myers Squibb Holdings Pharma, Ltd. (Pharmaceuticals), Manati, Puerto Rico, 23759-23760 [2019-10805]

Download as PDF khammond on DSKBBV9HB2PROD with NOTICES Federal Register / Vol. 84, No. 100 / Thursday, May 23, 2019 / Notices Reduction Act of 1995 (Pub. L. 104–113) and Office of Management and Budget regulations at 5 CFR part 1320. NASS also complies with OMB Implementation Guidance, ‘‘Implementation Guidance for Title V of the E-Government Act, Confidential Information Protection and Statistical Efficiency Act of 2002 (CIPSEA),’’ Federal Register, Vol. 72, No. 115, June 15, 2007, p. 33362. Estimate of Burden: Public reporting burden for this information collection is based on approximately 55 individual surveys with expected response times of 5–60 minutes. The frequency of data collection for the different surveys will include annual, seasonal, quarterly, monthly, and one weekly survey. Estimated number of responses per respondent is 1.1. Publicity materials and instruction sheets will account for approximately 5 minutes of additional burden per respondent. Respondents who refuse to complete a survey will be allotted 2 minutes of burden per attempt to collect the data. Several new surveys have been added to this information collection to account for some specialty commodities conducted under cooperative agreements with several States. Respondents: Producers, processors, and handlers. Estimated Number of Respondents: 75,000. Estimated Total Annual Burden on Respondents: 26,000 hours. Comments: Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information including the validity of the methodology and assumptions used; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on those who are to respond, through the use of appropriate automated, electronic, mechanical, technological or other forms of information technology collection methods. All responses to this notice will become a matter of public record and be summarized in the request for OMB approval. Signed at Washington, DC, May 2, 2019. Kevin L. Barnes, Associate Administrator. [FR Doc. 2019–10782 Filed 5–22–19; 8:45 am] BILLING CODE 3410–20–P VerDate Sep<11>2014 16:40 May 22, 2019 Jkt 247001 COMMISSION ON CIVIL RIGHTS Notice of Public Meeting of the Nevada Advisory Committee U.S. Commission on Civil Rights. ACTION: Announcement of meeting. AGENCY: Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act (FACA) that a meeting of the Nevada Advisory Committee (Committee) to the Commission will be held at 2:00 p.m. (Pacific Time) Thursday, May 30, 2019, the purpose of meeting is for the Committee to debrief the May 3, 2019 Community Forum. DATES: The meeting will be held on Thursday, May 30, 2019 at 2:00 p.m. PT. Public Call Information: Dial: 877– 260–1479, Conference ID: 6760059. FOR FURTHER INFORMATION CONTACT: Ana Victoria Fortes (DFO) at afortes@ usccr.gov or (213) 894–3437. SUPPLEMENTARY INFORMATION: This meeting is available to the public through the following toll-free call-in number: 877–260–1479, conference ID number: 6760059. Any interested member of the public may call this number and listen to the meeting. Callers can expect to incur charges for calls they initiate over wireless lines, and the Commission will not refund any incurred charges. Callers will incur no charge for calls they initiate over landline connections to the toll-free telephone number. Persons with hearing impairments may also follow the proceedings by first calling the Federal Relay Service at 1–800–877–8339 and providing the Service with the conference call number and conference ID number. Members of the public are entitled to make comments during the open period at the end of the meeting. Members of the public may also submit written comments; the comments must be received in the Regional Programs Unit within 30 days following the meeting. Written comments may be mailed to the Western Regional Office, U.S. Commission on Civil Rights, 300 North Los Angeles Street, Suite 2010, Los Angeles, CA 90012. They may be faxed to the Commission at (213) 894–0508, or emailed Ana Victoria Fortes at afortes@ usccr.gov. Persons who desire additional information may contact the Regional Programs Unit at (213) 894– 3437. Records and documents discussed during the meeting will be available for public viewing prior to and after the SUMMARY: PO 00000 Frm 00006 Fmt 4703 Sfmt 4703 23759 meeting at https:// www.facadatabase.gov/FACA/FACA PublicViewCommitteeDetails?id= a10t0000001gzlJAAQ. Records generated from this meeting may also be inspected and reproduced at the Regional Programs Unit, as they become available, both before and after the meeting. Persons interested in the work of this Committee are directed to the Commission’s website, http:// www.usccr.gov, or may contact the Regional Programs Unit at the above email or street address. Agenda I. Welcome II. Approval of Minutes for May 3, 2019 Community Forum III. Debrief May 3 Community Forum IV. Discuss Report Writing Schedule V. Public Comment VI. Next Steps VII. Adjournment Exceptional Circumstance: Pursuant to 41 CFR 102–3.150, the notice for this meeting is given less than 15 calendar days prior to the meeting because of the exceptional circumstances of the federal government shutdown. Dated: May 18, 2019. David Mussatt, Supervisory Chief, Regional Programs Unit. [FR Doc. 2019–10758 Filed 5–22–19; 8:45 am] BILLING CODE P DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–36–2019] Foreign-Trade Zone (FTZ) 7— Mayaguez, Puerto Rico, Notification of Proposed Production Activity, BristolMyers Squibb Holdings Pharma, Ltd. (Pharmaceuticals), Manati, Puerto Rico Bristol-Myers Squibb Holdings Pharma, Ltd. (BMS) submitted a notification of proposed production activity to the FTZ Board for its facility in Manati, Puerto Rico. The notification conforming to the requirements of the regulations of the FTZ Board (15 CFR 400.22) was received on May 13, 2019. BMS already has authority to produce certain pharmaceutical products within Subzone 7J. The current request would add finished products and a foreign status material/component to the scope of authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would be limited to the specific foreignstatus material/component and specific finished products described in the submitted notification (as described below) and subsequently authorized by the FTZ Board. E:\FR\FM\23MYN1.SGM 23MYN1 23760 Federal Register / Vol. 84, No. 100 / Thursday, May 23, 2019 / Notices Production under FTZ procedures could exempt BMS from customs duty payments on the foreign-status materials/components used in export production. On its domestic sales, for the foreign-status material/component noted below and in the existing scope of authority, BMS would be able to choose the duty rates during customs entry procedures that apply to pegbelfermin in measured and finished dosages (duty-free). BMS would be able to avoid duty on foreign-status components which become scrap/waste. Customs duties also could possibly be deferred or reduced on foreign-status production equipment. The material/component sourced from abroad is pegbelfermin—active pharmaceutical ingredient (duty-free). Public comment is invited from interested parties. Submissions shall be addressed to the Board’s Executive Secretary and sent to: ftz@trade.gov. The closing period for their receipt is July 2, 2019. A copy of the notification will be available for public inspection in the ‘‘Reading Room’’ section of the Board’s website, which is accessible via www.trade.gov/ftz. For further information, contact Christopher Wedderburn at Chris.Wedderburn@trade.gov or (202) 482–1963. Dated: May 17, 2019. Andrew McGilvray, Executive Secretary. DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B–77–2018] Foreign-Trade Zone (FTZ) 168—Dallas/ Fort Worth, Texas, Authorization of Production Activity, Gulfstream Aerospace Corporation (Disassembly of Aircraft), Dallas, Texas khammond on DSKBBV9HB2PROD with NOTICES [FR Doc. 2019–10806 Filed 5–22–19; 8:45 am] On December 7, 2018, the Metroplex International Trade Development Corporation, grantee of FTZ 168, submitted a notification of proposed production activity to the FTZ Board on behalf of Gulfstream Aerospace Corporation, within Subzone168E, in Dallas, Texas. The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (83 FR 64517–64518, December 17, 2018). On May 16, 2019, the applicant was notified of the FTZ Jkt 247001 DEPARTMENT OF COMMERCE International Trade Administration [C–570–085] Certain Quartz Surface Products From the People’s Republic of China: Final Affirmative Countervailing Duty Determination, and Final Affirmative Determination of Critical Circumstances BILLING CODE 3510–DS–P Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: The Department of Commerce (Commerce) determines that countervailable subsidies are being provided to producers and exporters of certain quartz surface products (quartz surface products) from the People’s Republic of China (China). DATES: Applicable May 23, 2019. FOR FURTHER INFORMATION CONTACT: Darla Brown or Joshua Tucker, AD/CVD Operations, Office II, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482–1791 or (202) 482–2044, respectively. AGENCY: DEPARTMENT OF COMMERCE International Trade Administration [C–489–832] Carbon and Alloy Steel Wire Rod From Turkey: Correction to Notice of Opportunity To Request Administrative Review Enforcement and Compliance, International Trade Administration, Department of Commerce. AGENCY: FOR FURTHER INFORMATION CONTACT: Brenda E. Waters, AD/CVD Operations, Customs Liaison Unit, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW, Washington, DC 20230; telephone: (202) 482–4735. Background BILLING CODE 3510–DS–P 16:40 May 22, 2019 Dated: May 16, 2019. Andrew McGilvray, Executive Secretary. SUPPLEMENTARY INFORMATION: [FR Doc. 2019–10805 Filed 5–22–19; 8:45 am] VerDate Sep<11>2014 Board’s decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board’s regulations, including Section 400.14. On May 1, 2019, Commerce published its notification to parties of the opportunity to request an administrative review of countervailing duty orders and inadvertently omitted Carbon and Alloy Steel Wire Rod from Turkey (C– 489–832), POR 9/5/2017–12/31/2018. See Antidumping or Countervailing Duty Order, Finding, or Suspended Investigation; Opportunity To Request Administrative Review, 84 FR 18479 (May 1, 2019). This notice serves as a correction to include the countervailing duty order Carbon and Alloy Steel Wire Rod from Turkey (C–489–832) administrative review in the referenced notice. Dated: May 16, 2019. Gary Taverman, Deputy Assistant Secretary for Antidumping and Countervailing Duty Operations. [FR Doc. 2019–10804 Filed 5–22–19; 8:45 am] BILLING CODE 3510–DS–P PO 00000 Frm 00007 Fmt 4703 Sfmt 4703 SUPPLEMENTARY INFORMATION: Background The petitioner in this investigation is Cambria Company, LLC. In addition to the Government of China (GOC), the mandatory respondents in this investigation are Fasa Industrial Corporation Limited (Fasa Industrial), Foshan Hero Stone Co., Ltd. (Hero Stone), and Foshan Yixin Stone Co., Ltd. (Foshan Yixin). The events that occurred since Commerce published the Preliminary Determination 1 on September 21, 2018; the post-preliminary analysis 2 on November 6, 2018; and the Preliminary Critical Circumstances Determination 3 on November 15, 2018, are discussed in the Issues and Decision Memorandum, 1 See Certain Quartz Surface Products from the People’s Republic of China: Preliminary Affirmative Countervailing Duty Determination, and Alignment of Final Determination with Final Antidumping Duty Determination, 83 FR 47881 (September 21, 2018) (Preliminary Determination), and accompanying Preliminary Decision Memorandum. 2 See Memorandum, ‘‘Post-Preliminary Analysis of Countervailing Duty Investigation: Certain Quartz Surface Products from the People’s Republic of China,’’ dated November 6, 2018. 3 See Certain Quartz Surface Products from the People’s Republic of China: Preliminary Affirmative Determination of Critical Circumstances, in Part, in the Countervailing Duty Investigation, 83 FR 57419 (November 15, 2018) (Preliminary Critical Circumstances Determination). E:\FR\FM\23MYN1.SGM 23MYN1

Agencies

[Federal Register Volume 84, Number 100 (Thursday, May 23, 2019)]
[Notices]
[Pages 23759-23760]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10805]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-36-2019]


Foreign-Trade Zone (FTZ) 7--Mayaguez, Puerto Rico, Notification 
of Proposed Production Activity, Bristol-Myers Squibb Holdings Pharma, 
Ltd. (Pharmaceuticals), Manati, Puerto Rico

    Bristol-Myers Squibb Holdings Pharma, Ltd. (BMS) submitted a 
notification of proposed production activity to the FTZ Board for its 
facility in Manati, Puerto Rico. The notification conforming to the 
requirements of the regulations of the FTZ Board (15 CFR 400.22) was 
received on May 13, 2019.
    BMS already has authority to produce certain pharmaceutical 
products within Subzone 7J. The current request would add finished 
products and a foreign status material/component to the scope of 
authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would 
be limited to the specific foreign-status material/component and 
specific finished products described in the submitted notification (as 
described below) and subsequently authorized by the FTZ Board.

[[Page 23760]]

    Production under FTZ procedures could exempt BMS from customs duty 
payments on the foreign-status materials/components used in export 
production. On its domestic sales, for the foreign-status material/
component noted below and in the existing scope of authority, BMS would 
be able to choose the duty rates during customs entry procedures that 
apply to pegbelfermin in measured and finished dosages (duty-free). BMS 
would be able to avoid duty on foreign-status components which become 
scrap/waste. Customs duties also could possibly be deferred or reduced 
on foreign-status production equipment.
    The material/component sourced from abroad is pegbelfermin--active 
pharmaceutical ingredient (duty-free).
    Public comment is invited from interested parties. Submissions 
shall be addressed to the Board's Executive Secretary and sent to: 
[email protected]. The closing period for their receipt is July 2, 2019.
    A copy of the notification will be available for public inspection 
in the ``Reading Room'' section of the Board's website, which is 
accessible via www.trade.gov/ftz.
    For further information, contact Christopher Wedderburn at 
[email protected] or (202) 482-1963.

    Dated: May 17, 2019.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2019-10805 Filed 5-22-19; 8:45 am]
BILLING CODE 3510-DS-P